HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Postmortem distribution of zipeprol.

Abstract
The abuse of zipeprol, an antitussive agent, is prevalent among young people in Korea. For its hallucinogenic effects, abusers have taken overdoses of the drug; thus, fatalities from zipeprol overdose have risen since 1991. In order to determine the postmortem distribution of zipeprol, tissues and blood from 23 decedents who had histories of drug abuse were examined. Homogenized tissue (1 g) and 1 mL blood were extracted by ethyl acetate. Cinnarizine was used as an internal standard. A Varian GC 4600 equipped with a thermionic specific detector was used to quantitate the drug using a DB-5 megabore column, and a Finnigan GC-MS model 4021 was used to obtain mass spectral identification of the extracts. The blood zipeprol concentrations varied from 2.3 to 38.3 micrograms/mL. The highest concentration of zipeprol was found in stomach tissue. Zipeprol concentrations in tissues were higher than the corresponding blood concentrations.
AuthorsY Yoo, H Chung, E Kim, M Kim
JournalJournal of analytical toxicology (J Anal Toxicol) 1994 Jul-Aug Vol. 18 Issue 4 Pg. 213-6 ISSN: 0146-4760 [Print] England
PMID7967542 (Publication Type: Journal Article)
Chemical References
  • Antitussive Agents
  • Piperazines
  • zipeprol
Topics
  • Adolescent
  • Adult
  • Antitussive Agents (blood, pharmacokinetics, poisoning)
  • Autopsy
  • Chromatography, Gas (methods)
  • Female
  • Humans
  • Male
  • Piperazines (blood, pharmacokinetics, poisoning)
  • Substance-Related Disorders (metabolism)
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: